103 related articles for article (PubMed ID: 19710100)
1. Expression of UDP-glucuronosyltransferase 1A6 isoform in Caco-2 cells stimulated with lipopolysaccharide.
Panaro MA; Cavallo P; Acquafredda A; Cianciulli A; Calvello R; Mitolo V
Innate Immun; 2010 Oct; 16(5):302-9. PubMed ID: 19710100
[TBL] [Abstract][Full Text] [Related]
2. The expression of most UDP-glucuronosyltransferases (UGTs) is increased significantly during Caco-2 cell differentiation, whereas UGT1A6 is highly expressed also in undifferentiated cells.
Siissalo S; Zhang H; Stilgenbauer E; Kaukonen AM; Hirvonen J; Finel M
Drug Metab Dispos; 2008 Nov; 36(11):2331-6. PubMed ID: 18694909
[TBL] [Abstract][Full Text] [Related]
3. UDP-glucuronosyltransferase 1A6: structural, functional, and regulatory aspects.
Bock KW; Köhle C
Methods Enzymol; 2005; 400():57-75. PubMed ID: 16399343
[TBL] [Abstract][Full Text] [Related]
4. UDP-glucuronosyltransferases 1A6 and 1A10 catalyze reduced menadione glucuronidation.
Nishiyama T; Ohnuma T; Inoue Y; Kishi T; Ogura K; Hiratsuka A
Biochem Biophys Res Commun; 2008 Jun; 371(2):247-50. PubMed ID: 18423374
[TBL] [Abstract][Full Text] [Related]
5. Effects of cell differentiation and assay conditions on the UDP-glucuronosyltransferase activity in Caco-2 cells.
Zhang H; Tolonen A; Rousu T; Hirvonen J; Finel M
Drug Metab Dispos; 2011 Mar; 39(3):456-64. PubMed ID: 21098645
[TBL] [Abstract][Full Text] [Related]
6. Quantitative analysis of UDP-glucuronosyltransferase (UGT) 1A and UGT2B expression levels in human livers.
Izukawa T; Nakajima M; Fujiwara R; Yamanaka H; Fukami T; Takamiya M; Aoki Y; Ikushiro S; Sakaki T; Yokoi T
Drug Metab Dispos; 2009 Aug; 37(8):1759-68. PubMed ID: 19439486
[TBL] [Abstract][Full Text] [Related]
7. Isoform-specific expression and induction of udp-glucuronosyltransferase in immunoactivated peritoneal macrophages of the rat.
Tochigi Y; Yamashiki N; Ohgiya S; Ganaha S; Yokota H
Drug Metab Dispos; 2005 Sep; 33(9):1391-8. PubMed ID: 15980103
[TBL] [Abstract][Full Text] [Related]
8. Cloning and characterization of a canine UDP-glucuronosyltransferase.
Soars MG; Smith DJ; Riley RJ; Burchell B
Arch Biochem Biophys; 2001 Jul; 391(2):218-24. PubMed ID: 11437353
[TBL] [Abstract][Full Text] [Related]
9. Glucuronidation and the UDP-glucuronosyltransferases in health and disease.
Wells PG; Mackenzie PI; Chowdhury JR; Guillemette C; Gregory PA; Ishii Y; Hansen AJ; Kessler FK; Kim PM; Chowdhury NR; Ritter JK
Drug Metab Dispos; 2004 Mar; 32(3):281-90. PubMed ID: 14977861
[TBL] [Abstract][Full Text] [Related]
10. Cloning and expression of human UDP-glucuronosyltransferase (UGT) 1A8.
Cheng Z; Radominska-Pandya A; Tephly TR
Arch Biochem Biophys; 1998 Aug; 356(2):301-5. PubMed ID: 9705221
[TBL] [Abstract][Full Text] [Related]
11. Identification of human UDP-glucuronosyltransferase isoform(s) responsible for the C-glucuronidation of phenylbutazone.
Nishiyama T; Kobori T; Arai K; Ogura K; Ohnuma T; Ishii K; Hayashi K; Hiratsuka A
Arch Biochem Biophys; 2006 Oct; 454(1):72-9. PubMed ID: 16949544
[TBL] [Abstract][Full Text] [Related]
12. Polymorphic expression of the UDP-glucuronosyltransferase UGT1A gene locus in human gastric epithelium.
Strassburg CP; Nguyen N; Manns MP; Tukey RH
Mol Pharmacol; 1998 Oct; 54(4):647-54. PubMed ID: 9765507
[TBL] [Abstract][Full Text] [Related]
13. Human udp-glucuronosyltransferases: isoform selectivity and kinetics of 4-methylumbelliferone and 1-naphthol glucuronidation, effects of organic solvents, and inhibition by diclofenac and probenecid.
Uchaipichat V; Mackenzie PI; Guo XH; Gardner-Stephen D; Galetin A; Houston JB; Miners JO
Drug Metab Dispos; 2004 Apr; 32(4):413-23. PubMed ID: 15039294
[TBL] [Abstract][Full Text] [Related]
14. Natural and synthetic inhibitors of UDP-glucuronosyltransferase.
Grancharov K; Naydenova Z; Lozeva S; Golovinsky E
Pharmacol Ther; 2001 Feb; 89(2):171-86. PubMed ID: 11316519
[TBL] [Abstract][Full Text] [Related]
15. Functions and transcriptional regulation of adult human hepatic UDP-glucuronosyl-transferases (UGTs): mechanisms responsible for interindividual variation of UGT levels.
Bock KW
Biochem Pharmacol; 2010 Sep; 80(6):771-7. PubMed ID: 20457141
[TBL] [Abstract][Full Text] [Related]
16. The UDP-glucuronosyltransferases: their role in drug metabolism and detoxification.
Rowland A; Miners JO; Mackenzie PI
Int J Biochem Cell Biol; 2013 Jun; 45(6):1121-32. PubMed ID: 23500526
[TBL] [Abstract][Full Text] [Related]
17. Studies on the substrate specificity of human intestinal UDP- lucuronosyltransferases 1A8 and 1A10.
Cheng Z; Radominska-Pandya A; Tephly TR
Drug Metab Dispos; 1999 Oct; 27(10):1165-70. PubMed ID: 10497143
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of acetaminophen glucuronidation by UDP-glucuronosyltransferases 1A1, 1A6, 1A9 and 2B15. Potential implications in acetaminophen-induced hepatotoxicity.
Mutlib AE; Goosen TC; Bauman JN; Williams JA; Kulkarni S; Kostrubsky S
Chem Res Toxicol; 2006 May; 19(5):701-9. PubMed ID: 16696573
[TBL] [Abstract][Full Text] [Related]
19. Induction of UDP-glucuronosyltransferase UGT1A1 by the flavonoid chrysin in the human hepatoma cell line hep G2.
Walle T; Otake Y; Galijatovic A; Ritter JK; Walle UK
Drug Metab Dispos; 2000 Sep; 28(9):1077-82. PubMed ID: 10950852
[TBL] [Abstract][Full Text] [Related]
20. UDP-glucuronosyltransferases and clinical drug-drug interactions.
Kiang TK; Ensom MH; Chang TK
Pharmacol Ther; 2005 Apr; 106(1):97-132. PubMed ID: 15781124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
